2019
SJR Q2
JCR Q2 · 3,6
OA
16 matched articles
ESCI
Journal detail
World Journal of Clinical Oncology (discontinued)
- Publisher
- Baishideng Publishing Group Co
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
22184333
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,003
- Quartile Q2
- H-Index 50
- Cites/doc 3,17
- Docs (3y) 124
- Cites (3y) 410
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,6
- 5Y JIF 3,8
- JCI 0,49
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Oncology Q2
Areas
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | — | Q2 | — | 3,6 | 3,8 | 0,49 | Q3 | — |
| 2024 | — | Q2 | — | 3,2 | 3,2 | 0,45 | Q3 | — |
| 2023 | — | Q3 | — | 2,6 | 2,7 | 0,41 | Q3 | — |
| 2022 | — | — | — | 2,8 | 3 | 0,37 | Q4 | — |
| 2021 | — | — | — | — | — | 0,35 | Q4 | — |
| 2020 | — | — | — | — | — | 0,48 | Q3 | — |
| 2019 | Q2 | — | 1,003 | — | — | — | — | 50 |
| 2017 | Q1 | — | 1,358 | — | — | — | — | 50 |
| 2016 | Q1 | — | 1,467 | — | — | — | — | 50 |
| 2015 | Q2 | — | 1,317 | — | — | — | — | 50 |
| 2014 | — | — | — | — | — | — | — | 50 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | ESCI | Q2 | Q3 | 132/333 |
| 2024 | ONCOLOGY | ESCI | Q2 | Q3 | 130/328 |
| 2023 | ONCOLOGY | ESCI | Q3 | Q3 | 175/322 |
| 2022 | ONCOLOGY | ESCI | — | Q4 | — |
| 2021 | ONCOLOGY | ESCI | — | Q4 | — |
| 2020 | ONCOLOGY | ESCI | — | Q3 | — |